Fighting Blindness Canada funded researcher Dr. Sachdev Sidhu (University of Waterloo) has developed a novel antibody therapy that will now be tested in a Phase 1/2 human clinical trial. An intact blood-retinal barrier is important for proper retinal function. This is disrupted in eye diseases such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Read More